Announcements - Search results

Search results: Company announcements for
ANTISENSE THERAPEUTICS LIMITED (ANP)
Released between 01/01/2013 and 31/12/2013

Didn't find the announcement you were after? Search again.

Announcements released as ANP
Date Price sens. Headline
24/12/2013
9:34 AM
  Change of Director's Interest Notice (MD)
2 pages 23.4KB
24/12/2013
9:34 AM
  Change of Director's Interest Notice (GM)
2 pages 23.3KB
24/12/2013
9:29 AM
  Change of Director's Interest Notice (CB)
2 pages 23.4KB
24/12/2013
9:29 AM
  Change of Director's Interest Notice (RM)
2 pages 23.3KB
24/12/2013
8:54 AM
  Appendix 3B & ANPO Top Holder Report
14 pages 250.4KB
23/12/2013
2:04 PM
asterix ATL1103 Phase II Trial Positive Interim Results
3 pages 105.4KB
20/12/2013
12:37 PM
  Completion of Loyalty Issue of Options
1 page 22.4KB
20/12/2013
9:34 AM
  Request for Trading Halt
1 page 50.3KB
20/12/2013
9:33 AM
asterix Trading Halt
1 page 77.4KB
12/12/2013
9:31 AM
asterix ATL1102 for MS Toxicology Dosing Completed
1 page 21.3KB
29/11/2013
8:25 AM
asterix ATL1102 for Stem Cell Mobilisation Trial Application
2 pages 33.3KB
27/11/2013
9:29 AM
asterix ATL1103 Phase II Trial Update
2 pages 84.2KB
25/11/2013
12:30 PM
  Clarification of Loyalty Options Offer timetable
1 page 18.0KB
21/11/2013
4:17 PM
  Letter to Shareholders
3 pages 45.6KB
21/11/2013
11:49 AM
asterix Loyalty Issue Offer Prospectus
36 pages 289.4KB
21/11/2013
10:01 AM
  Appendix 3B
12 pages 149.7KB
13/11/2013
10:31 AM
  Letter to Shareholders - Stock Consolidation
2 pages 28.6KB
11/11/2013
9:01 AM
asterix Receipt of R&D Tax Incentive
1 page 20.1KB
01/11/2013
11:44 AM
  Results of Meeting
1 page 82.3KB
01/11/2013
9:36 AM
  AGM Presentation
16 pages 278.8KB
29/10/2013
9:06 AM
asterix Appendix 4C - quarterly
5 pages 43.9KB
28/10/2013
9:00 AM
  ANP to Present at Australia Biotech Invest 2013
1 page 21.4KB
25/10/2013
9:54 AM
  Acromegaly Scientific Conference Presentation
1 page 64.5KB
23/10/2013
9:37 AM
  ANP to Present at BioTech and Healthcare Investor Roadshow
14 pages 478.0KB
17/10/2013
12:13 PM
  Article on ANP by Genetic Engineering and Biotechnology News
1 page 21.0KB
17/10/2013
9:58 AM
asterix ATL1103 Phase II Trial Update - Interim Analysis
2 pages 58.5KB
11/10/2013
11:47 AM
  Bloomberg Brief US Interview
1 page 58.6KB
01/10/2013
4:52 PM
  Notice of Annual General Meeting and Annual Report
83 pages 1.9MB
01/10/2013
9:06 AM
asterix ATL1102 for Stem Cell Mobilisation
2 pages 34.7KB
27/09/2013
8:56 AM
asterix Proposed Consolidation of Securities & Loyalty Option Issue
3 pages 34.1KB
25/09/2013
9:03 AM
asterix ATL1102 for Multiple Sclerosis
2 pages 31.3KB
11/09/2013
9:05 AM
  Rodman & Renshaw Global Investment Conference Presentation
21 pages 770.8KB
28/08/2013
9:35 AM
  ANP at Major US Investment Partnering & Industry Conferences
1 page 64.6KB
16/08/2013
8:29 AM
asterix Appendix 4E Preliminary Final Report and Statutory Accounts
79 pages 1.7MB
02/08/2013
10:54 AM
asterix ATL1103 Phase II Trial Update
2 pages 33.5KB
01/08/2013
11:47 AM
asterix Trading Halt
2 pages 274.4KB
23/07/2013
9:06 AM
asterix Appendix 4C - quarterly
5 pages 42.8KB
22/07/2013
12:57 PM
  Form 604 - Change in Substantial Shareholder (J&C Constable)
2 pages 720.6KB
12/07/2013
5:07 PM
  Change of Registered Office
1 page 62.3KB
09/07/2013
9:38 AM
asterix Response to ASX Price Query
4 pages 168.0KB
02/07/2013
9:56 AM
  Appendix 3B
11 pages 187.0KB
14/06/2013
9:32 AM
asterix Positive New Animal Data on ATL1103
4 pages 154.1KB
04/06/2013
8:35 AM
asterix ATL1102 for MS - Dosing Starts in Key Toxicology Study
2 pages 43.1KB
13/05/2013
9:13 AM
  Change of Director's Interest Notice - RM
2 pages 24.9KB
01/05/2013
9:36 AM
asterix ATL1102 for Multiple Sclerosis -Toxicology Study to Commence
2 pages 37.3KB
30/04/2013
11:36 AM
asterix Appendix 4C - quarterly
5 pages 42.8KB
17/04/2013
4:43 PM
  Change of Director's Interest Notice (MD)
2 pages 20.4KB
10/04/2013
9:20 AM
asterix ATL1103 Phase II trial - dosing of patients commences
2 pages 31.3KB
08/04/2013
9:30 AM
  Antisense Newsletter
5 pages 564.0KB
25/03/2013
8:47 AM
  Change of Director's Interest Notice - MD
2 pages 19.5KB
22/03/2013
9:53 AM
  ATL1103 Phase I data presentation at Acromegaly Conference
1 page 23.8KB
19/03/2013
9:58 AM
asterix ATL1102 Development and Agreement Update
2 pages 38.7KB
15/03/2013
8:56 AM
  ANP to Present at ROTH Capital Partners Conference
1 page 22.8KB
13/03/2013
9:45 AM
  Investor Presentation
12 pages 217.5KB
26/02/2013
5:29 PM
asterix Half Yearly Report and Accounts
27 pages 2.3MB
14/02/2013
11:51 AM
  Becoming a substantial holder
2 pages 101.4KB
12/02/2013
9:35 AM
asterix ATL1102 US Patent Allowance and Development Progress
2 pages 32.1KB
04/02/2013
9:02 AM
  ANP to Present at BIO CEO and Investor Conference
1 page 22.6KB
30/01/2013
12:28 PM
asterix FDA Approval of KYNAMRO
7 pages 89.7KB
30/01/2013
10:27 AM
asterix Trading Halt
2 pages 116.3KB
25/01/2013
8:57 AM
asterix ATL1103 Phase II trial - patient enrolment commences
2 pages 30.3KB
14/01/2013
1:46 PM
  Appendix 4C - quarterly - Minor amendment
5 pages 43.2KB
14/01/2013
9:49 AM
asterix Appendix 4C - quarterly
5 pages 43.3KB

Useful Information

Other companies that have used the code 'ANP'

  • AUSTRALIAN PETROLEUM FUND - previously known as
  • BA PETROLEUM EXPLORERS TRUST

view available announcements for this company

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.